241 related articles for article (PubMed ID: 26215971)
1. IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells.
Lissat A; Joerschke M; Shinde DA; Braunschweig T; Meier A; Makowska A; Bortnick R; Henneke P; Herget G; Gorr TA; Kontny U
BMC Cancer; 2015 Jul; 15():552. PubMed ID: 26215971
[TBL] [Abstract][Full Text] [Related]
2. Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors.
Anderson JL; Titz B; Akiyama R; Komisopoulou E; Park A; Tap WD; Graeber TG; Denny CT
Mol Cancer Res; 2014 Dec; 12(12):1740-54. PubMed ID: 25092916
[TBL] [Abstract][Full Text] [Related]
3. An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning.
Ren EH; Deng YJ; Yuan WH; Wu ZL; Zhang GZ; Xie QQ
J Cancer Res Clin Oncol; 2021 Jan; 147(1):153-165. PubMed ID: 32968877
[TBL] [Abstract][Full Text] [Related]
4. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.
Garcia-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Herrero-Martín D; Huertas-Martinez J; Lagares-Tena L; Alba-Pavón P; Hontecillas-Prieto L; Mora J; de Álava E; Rello-Varona S; Giangrande PH; Tirado OM
Int J Cancer; 2018 Sep; 143(5):1188-1201. PubMed ID: 29582409
[TBL] [Abstract][Full Text] [Related]
5. Effects of baicalein on proliferation, apoptosis, migration and invasion of Ewing's sarcoma cells.
Ye C; Yu X; Zeng J; Dai M; Zhang B
Int J Oncol; 2017 Dec; 51(6):1785-1792. PubMed ID: 29039470
[TBL] [Abstract][Full Text] [Related]
6. The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6.
Yin Y; Yao S; Hu Y; Feng Y; Li M; Bian Z; Zhang J; Qin Y; Qi X; Zhou L; Fei B; Zou J; Hua D; Huang Z
Clin Cancer Res; 2017 Dec; 23(23):7375-7387. PubMed ID: 28928161
[No Abstract] [Full Text] [Related]
7. Tumor suppressive ZBTB4 inhibits cell growth by regulating cell cycle progression and apoptosis in Ewing sarcoma.
Yu Y; Shang R; Chen Y; Li J; Liang Z; Hu J; Liu K; Chen C
Biomed Pharmacother; 2018 Apr; 100():108-115. PubMed ID: 29425745
[TBL] [Abstract][Full Text] [Related]
8. Modeling Stroma-Induced Drug Resistance in a Tissue-Engineered Tumor Model of Ewing Sarcoma.
Santoro M; Menegaz BA; Lamhamedi-Cherradi SE; Molina ER; Wu D; Priebe W; Ludwig JA; Mikos AG
Tissue Eng Part A; 2017 Jan; 23(1-2):80-89. PubMed ID: 27923328
[TBL] [Abstract][Full Text] [Related]
9. SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration.
Indovina P; Casini N; Forte IM; Garofano T; Cesari D; Iannuzzi CA; Del Porro L; Pentimalli F; Napoliello L; Boffo S; Schenone S; Botta M; Giordano A
J Cell Physiol; 2017 Jan; 232(1):129-35. PubMed ID: 27037775
[TBL] [Abstract][Full Text] [Related]
10. ERBB4 confers metastatic capacity in Ewing sarcoma.
Mendoza-Naranjo A; El-Naggar A; Wai DH; Mistry P; Lazic N; Ayala FR; da Cunha IW; Rodriguez-Viciana P; Cheng H; Tavares Guerreiro Fregnani JH; Reynolds P; Arceci RJ; Nicholson A; Triche TJ; Soares FA; Flanagan AM; Wang YZ; Strauss SJ; Sorensen PH
EMBO Mol Med; 2013 Jul; 5(7):1087-102. PubMed ID: 23681745
[TBL] [Abstract][Full Text] [Related]
11. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
12. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival.
Tilan JU; Krailo M; Barkauskas DA; Galli S; Mtaweh H; Long J; Wang H; Hawkins K; Lu C; Jeha D; Izycka-Swieszewska E; Lawlor ER; Toretsky JA; Kitlinska JB
Cancer; 2015 Mar; 121(5):697-707. PubMed ID: 25387699
[TBL] [Abstract][Full Text] [Related]
13. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
Int J Oncol; 2016 Apr; 48(4):1531-40. PubMed ID: 26846737
[TBL] [Abstract][Full Text] [Related]
15. Cadherin-11 regulates the metastasis of Ewing sarcoma cells to bone.
Hatano M; Matsumoto Y; Fukushi J; Matsunobu T; Endo M; Okada S; Iura K; Kamura S; Fujiwara T; Iida K; Fujiwara Y; Nabeshima A; Yokoyama N; Fukushima S; Oda Y; Iwamoto Y
Clin Exp Metastasis; 2015 Aug; 32(6):579-91. PubMed ID: 26092671
[TBL] [Abstract][Full Text] [Related]
16. Chikusetsusaponin IVa Butyl Ester (CS-IVa-Be), a Novel IL6R Antagonist, Inhibits IL6/STAT3 Signaling Pathway and Induces Cancer Cell Apoptosis.
Yang J; Qian S; Cai X; Lu W; Hu C; Sun X; Yang Y; Yu Q; Gao SP; Cao P
Mol Cancer Ther; 2016 Jun; 15(6):1190-200. PubMed ID: 26929249
[TBL] [Abstract][Full Text] [Related]
17. In vitro antiproliferative and antimigratory activity of dasatinib in neuroblastoma and Ewing sarcoma cell lines.
Timeus F; Crescenzio N; Fandi A; Doria A; Foglia L; Cordero di Montezemolo L
Oncol Rep; 2008 Feb; 19(2):353-9. PubMed ID: 18202781
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-Specific Protease 6 Functions as a Tumor Suppressor in Ewing Sarcoma through Immune Activation.
Henrich IC; Jain K; Young R; Quick L; Lindsay JM; Park DH; Oliveira AM; Blobel GA; Chou MM
Cancer Res; 2021 Apr; 81(8):2171-2183. PubMed ID: 33558334
[TBL] [Abstract][Full Text] [Related]
19. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth.
Wang H; Lathia JD; Wu Q; Wang J; Li Z; Heddleston JM; Eyler CE; Elderbroom J; Gallagher J; Schuschu J; MacSwords J; Cao Y; McLendon RE; Wang XF; Hjelmeland AB; Rich JN
Stem Cells; 2009 Oct; 27(10):2393-404. PubMed ID: 19658188
[TBL] [Abstract][Full Text] [Related]
20. Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy.
Sand LG; Berghuis D; Szuhai K; Hogendoorn PC
Cancer Immunol Immunother; 2016 Aug; 65(8):995-1002. PubMed ID: 27369431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
